Related Experiment Videos
Apoptosis, complement and systemic lupus erythematosus: a mechanistic view.
Chau-Ching Liu1, Jeannine S Navratil, Janice M Sabatine
1Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Lupus Center of Excellence, University of Pittsburgh Schools of the Health Sciences, Pittsburgh, Pa., USA.
Current Directions in Autoimmunity
|January 15, 2004
Summary
Deficiencies in the classical complement pathway are linked to systemic lupus erythematosus (SLE). This connection involves complement
Area of Science:
- Immunology
- Molecular Biology
- Pathogenesis of Autoimmune Diseases
Background:
- Classical complement pathway deficiencies are historically linked to systemic lupus erythematosus (SLE) etiology.
- Emerging research highlights complement's crucial role in clearing apoptotic cellular debris.
- Dysfunctional apoptosis contributes to autoimmune responses.
Purpose of the Study:
- To review the role of apoptosis in initiating autoimmune responses.
- To integrate recent findings on the link between apoptosis, complement activation, and SLE pathogenesis.
- To provide a comprehensive overview of the etiopathogenesis of SLE concerning apoptosis and complement.
Main Methods:
- Literature review of immunological and molecular studies.
- Synthesis of recent research on complement system function in SLE.
- Analysis of the interplay between apoptosis, immune clearance, and autoimmune disease development.
Main Results:
- Apoptosis generates cellular remnants that can trigger autoimmune responses.
- Complement activation, particularly the classical pathway, is vital for recognizing and clearing these remnants.
- Impaired clearance due to complement deficiencies exacerbates SLE pathogenesis.
Conclusions:
- Effective clearance of apoptotic debris by the complement system is essential for preventing autoimmunity.
- Deficiencies in the classical complement pathway are a significant factor in SLE development.
- Understanding the apoptosis-complement axis offers insights into SLE etiopathogenesis and potential therapeutic targets.